- 米国企業
- EAGLE PHARMACEUTICALS, INC.
EAGLE PHARMACEUTICALS, INC.EGRX
| 2014年 9月30日 | 2015年 12月31日 | 2016年 12月31日 | 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 |
---|
Cash and cash equivalents | 23 | 79 | 53 | 115 | 79 | 110 | 103 | 98 | 55 |
---|
Accounts receivable, net | 7 | 26 | 42 | 54 | 66 | 48 | 51 | 41 | 72 |
---|
Inventories | 1 | 15 | 3 | 5 | 8 | 7 | 8 | 22 | 48 |
---|
Prepaid expenses and other current assets | 2 | 2 | 11 | 15 | 10 | 15 | 4 | 12 | 13 |
---|
Total current assets | 53 | 122 | 109 | 189 | 164 | 179 | 166 | 173 | 189 |
---|
Property and equipment, net | 0 | 2 | 3 | 7 | 2 | 2 | 2 | 2 | 1 |
---|
Intangible assets, net | - | - | 33 | 23 | 18 | 16 | 13 | 11 | 118 |
---|
Goodwill | - | - | 40 | 40 | 40 | 40 | 40 | 40 | 45 |
---|
Deferred tax asset | - | - | 29 | 11 | 14 | 14 | 15 | 19 | 27 |
---|
Other assets | 0 | 0 | 0 | 0 | 1 | 4 | 17 | 10 | 26 |
---|
Total assets | 53 | 125 | 214 | 270 | 239 | 255 | 253 | 254 | 406 |
---|
Accounts payable | 4 | 4 | 15 | 12 | 10 | 5 | 6 | 16 | 19 |
---|
Accrued Liabilities, Current | 10 | 24 | 25 | 15 | 24 | 28 | 24 | 32 | 86 |
---|
Short-term debt | - | - | - | 5 | 6 | 5 | 8 | 26 | 6 |
---|
Total current liabilities | 20 | 34 | 41 | 47 | 40 | 39 | 38 | 74 | 111 |
---|
Other long-term liabilities | - | - | - | - | - | 3 | 4 | 3 | 5 |
---|
Long-term debt | - | - | - | 43 | 38 | 34 | 25 | - | 56 |
---|
Total liabilities | - | - | - | - | - | 75 | 67 | 77 | 173 |
---|
Preferred Stock, Value, Issued | - | - | - | - | - | - | - | - | - |
---|
Common Stock, Value, Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
---|
Additional paid in capital | 137 | 197 | 214 | 234 | 256 | 279 | 305 | 326 | 366 |
---|
Accumulated other comprehensive loss | - | - | - | - | - | - | - | -0 | -1 |
---|
Retained earnings | -104 | -107 | -26 | 26 | 58 | 73 | 84 | 76 | 112 |
---|
Treasury stock, at cost, 4,552,730 and 4,111,622 shares as of December 31, 2022 and 2021, respectively | - | - | 37 | 81 | 154 | 172 | 204 | 225 | 243 |
---|
Total stockholders' equity | 33 | 90 | 151 | 179 | 161 | 179 | 186 | 176 | 234 |
---|
Total liabilities and stockholders' equity | 53 | 125 | 214 | 270 | 239 | 255 | 253 | 254 | 406 |
---|